Related Experiment Video

Updated: Jun 18, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

A mutation in the beta-myosin rod associated with hypertrophic cardiomyopathy has an unexpected molecular phenotype

Thomas Z Armel1, Leslie A Leinwand

  • 1Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO 80309, USA.

Biochemical and Biophysical Research Communications
|November 17, 2009
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) is linked to mutations in beta-myosin heavy chain (beta-MyHC). A specific mutation destabilizes the protein, impairing filament formation and potentially causing HCM.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Protein Biochemistry

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic heart disease causing left ventricular hypertrophy and sudden death.
  • Mutations in sarcomeric proteins, particularly MYH7 encoding beta-myosin heavy chain (beta-MyHC), are primary causes of HCM.
  • HCM-associated mutations in the beta-MyHC rod domain remain understudied compared to the globular head region.

Purpose of the Study:

  • To investigate the structural, stability, and functional impact of the E1356K mutation in the beta-MyHC rod domain.
  • To elucidate the molecular mechanisms by which this specific mutation contributes to hypertrophic cardiomyopathy.

Main Methods:

  • Biochemical assays
  • Biophysical assays
  • Protein stability analysis
  • Muscle filament formation studies

Main Results:

  • The E1356K mutation was found to thermodynamically destabilize the beta-MyHC protein.
  • This destabilization, rather than altered charge, appears critical for the mutation's effect.
  • Decreased protein stability led to impaired ability to form muscle filaments.

Conclusions:

  • The E1356K mutation destabilizes the beta-MyHC rod domain, impacting filament formation.
  • Thermodynamic instability is a key mechanism underlying HCM caused by this mutation.
  • Findings provide new insights into the molecular basis of hypertrophic cardiomyopathy.

More Related Videos

Probing Myosin Ensemble Mechanics in Actin Filament Bundles Using Optical Tweezers06:53

Probing Myosin Ensemble Mechanics in Actin Filament Bundles Using Optical Tweezers

Published on: May 4, 2022

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mutations01:39

Mutations

Overview
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...